Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$41.12 - $57.73 $35,363 - $49,647
860 Added 0.22%
395,810 $17.3 Million
Q2 2023

Aug 07, 2023

SELL
$40.44 - $49.6 $146,716 - $179,948
-3,628 Reduced 0.91%
394,950 $19.5 Million
Q1 2023

May 03, 2023

SELL
$35.87 - $47.22 $95,629 - $125,888
-2,666 Reduced 0.66%
398,578 $16.5 Million
Q4 2022

Feb 10, 2023

SELL
$33.48 - $47.45 $199,105 - $282,185
-5,947 Reduced 1.46%
401,244 $17.8 Million
Q3 2022

Oct 24, 2022

BUY
$38.25 - $52.62 $7.09 Million - $9.76 Million
185,481 Added 83.66%
407,191 $15.9 Million
Q2 2022

Jul 22, 2022

BUY
$35.1 - $66.01 $7.78 Million - $14.6 Million
221,710 New
221,710 $9.06 Million

Others Institutions Holding ATRC

About AtriCure, Inc.


  • Ticker ATRC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 46,424,700
  • Market Cap $1.43B
  • Description
  • AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...
More about ATRC
Track This Portfolio

Track Granite Investment Partners, LLC Portfolio

Follow Granite Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Investment Partners, LLC with notifications on news.